Related Experiment Video
Updated: Jul 31, 2025

09:16
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
15.3K
Methamphetamine exposure and depression-A systematic review and meta-analysis
Janni Leung1,2,3, Tesfa Mekonen1,2,4, XiaoXuan Wang1,2
1National Centre for Youth Substance Use Research, The University of Queensland, Brisbane, Australia.
Drug and Alcohol Review
|May 1, 2023
Summary
Methamphetamine use significantly increases the odds of depression. This systematic review and meta-analysis found a clear link, with a low risk of unmeasured confounding in longitudinal data.
Area of Science:
- Public Health
- Mental Health
- Addiction Medicine
Background:
- Methamphetamine use is a significant public health issue.
- It is frequently associated with co-occurring mental health conditions, particularly depression.
- Understanding this relationship is crucial for effective intervention strategies.
Approach:
- A systematic review and meta-analysis adhering to PRISMA guidelines.
- Searched EMBASE, PsycINFO, and PubMed for human studies on methamphetamine/amphetamine use and depression.
- Assessed unmeasured confounding using E-value analyses.
Key Points:
- 14 studies were included, revealing a significant association between methamphetamine use and depression.
- Cross-sectional estimates showed an odds ratio (OR) of 1.66 (95% CI 1.34–2.05).
- Longitudinal estimates indicated an OR of 1.18 (95% CI 1.08–1.28), with higher odds for those with a methamphetamine use disorder (OR = 2.80, 95% CI 1.40–5.90).
Conclusions:
- Individuals using methamphetamine exhibit higher odds of depression.
- Longitudinal study results demonstrated a low to moderate risk of unmeasured confounding.
- Further research using causal framework methods is recommended to solidify findings.
Related Concept Videos
Depression: Overview
301
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
301
Depressive Disorders: Etiology
147
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
147
Antidepressant Drugs: MAOIs and Other Agents
286
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
286
Stress and Mental Health
189
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
189
Attention-Deficit/Hyperactivity Disorder
134
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
134

